Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable ce:italic>Haemophilus influenzae/ce:italic> protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study

著录项

• 来源
  《Vaccine》 |2018年第5期|共9页
• 作者

  Khalequ Zaman; Sheikh Farzana Zaman; Farzana Zaman; Asma Aziz; Sayeed-Bin Faisal; Magali Traskine; Md Ahsan Habib; Javier Ruiz-Gui?azú; Dorota Borys;

  展开▼
• 作者单位

  International Centre for Diarrheal Disease Research Bangladesh (icddr b);

  International Centre for Diarrheal Disease Research Bangladesh (icddr b);

  International Centre for Diarrheal Disease Research Bangladesh (icddr b);

  International Centre for Diarrheal Disease Research Bangladesh (icddr b);

  International Centre for Diarrheal Disease Research Bangladesh (icddr b);

  GSK;

  GSK;

  GSK;

  GSK;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 other
• 中图分类 医学免疫学;
• 关键词

  Pneumococcal non-typeableHaemophilus influenzaeprotein D-conjugate vaccine (PHiD-CV); 1-dose vial presentation; 4-dose vial presentation; Immunologic non-inferiority; Safety; Infants;

  机译：肺炎球菌非典型的Hemophilus流感蛋白D-缀合物疫苗（phid-cv）;1剂小瓶呈现;4剂小瓶呈现;免疫学不劣等;安全;婴儿;